JP5826586B2 - Solid drug supply apparatus and solid drug supply method - Google Patents

Solid drug supply apparatus and solid drug supply method Download PDF

Info

Publication number
JP5826586B2
JP5826586B2 JP2011230453A JP2011230453A JP5826586B2 JP 5826586 B2 JP5826586 B2 JP 5826586B2 JP 2011230453 A JP2011230453 A JP 2011230453A JP 2011230453 A JP2011230453 A JP 2011230453A JP 5826586 B2 JP5826586 B2 JP 5826586B2
Authority
JP
Japan
Prior art keywords
drug
solution
solid
solvent
filling container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2011230453A
Other languages
Japanese (ja)
Other versions
JP2013086045A (en
Inventor
吉川 浩
浩 吉川
泰広 高岡
泰広 高岡
千晴 大森
千晴 大森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organo Corp
Original Assignee
Organo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organo Corp filed Critical Organo Corp
Priority to JP2011230453A priority Critical patent/JP5826586B2/en
Publication of JP2013086045A publication Critical patent/JP2013086045A/en
Application granted granted Critical
Publication of JP5826586B2 publication Critical patent/JP5826586B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Accessories For Mixers (AREA)
  • Feeding, Discharge, Calcimining, Fusing, And Gas-Generation Devices (AREA)

Description

本発明は、固形薬剤供給装置および固形薬剤供給方法に関する。   The present invention relates to a solid drug supply device and a solid drug supply method.

水処理等の分野では、各種固形薬剤(殺菌剤、分散剤、防食剤等)が用いられている。従来の固形薬剤の溶解・供給システムとしては、例えば、高分子凝集剤の自動溶解機等が知られている(例えば、非特許文献1参照)。   In the field of water treatment and the like, various solid drugs (bactericide, dispersant, anticorrosive, etc.) are used. As a conventional solid drug dissolving / supplying system, for example, an automatic dissolving machine for a polymer flocculant is known (for example, see Non-Patent Document 1).

しかし、このような装置では、固形薬剤の補充等の際に、固形薬剤およびその溶解液が作業者に接触する可能性がある。また、自動給粉機や撹拌機等が必要であり、装置が大掛かりになるという問題がある。   However, in such an apparatus, there is a possibility that the solid medicine and its solution come into contact with the operator when the solid medicine is replenished. Moreover, an automatic powder feeder, a stirrer, etc. are required and there exists a problem that an apparatus becomes large.

その他の固形薬剤の溶解・供給システムとしては、固形薬剤を充填した薬剤充填容器を直接被処理水系の配管(バイパス配管等)に組み込み、そこに被処理水、または被処理水の一部を供給することにより固形薬剤を溶解させ、その(過)飽和溶解液を直接被処理水系へ供給するシステムが知られている(例えば、特許文献1の図1参照)。   For other solid drug dissolution and supply systems, a drug filling container filled with a solid drug is directly incorporated into the pipe (bypass pipe, etc.) of the water to be treated, and the water to be treated or a part of the water to be treated is supplied to it. Thus, a system is known in which a solid drug is dissolved and the (super) saturated solution is directly supplied to the water to be treated (see, for example, FIG. 1 of Patent Document 1).

しかし、これらのシステムでは、被処理水の温度低下等の温度変動等があった場合、被処理水系の中で薬剤が過飽和となって析出し、被処理水系の配管(主配管、バイパス配管等)が閉塞する可能性があるという問題がある。また、被処理水中の薬剤濃度を調整することが困難である。   However, in these systems, when there are temperature fluctuations such as a decrease in the temperature of the water to be treated, the chemicals are supersaturated in the water to be treated, and the piping of the water to be treated (main piping, bypass piping, etc.) ) May become blocked. Moreover, it is difficult to adjust the chemical concentration in the water to be treated.

また、特許文献2には、液体浸漬時に溶解して溶液を形成する固形化学薬品を各々収容する2以上の供給ボウルを備え、片方のボウルが空になった時に、一方の供給ボウルから他方のボウルへの固形化学薬品の溶解した溶液の切換を自動的に行う機能が組み込まれた複式固形化学薬品供給システムが記載されている。   Patent Document 2 also includes two or more supply bowls each containing solid chemicals that dissolve during liquid immersion to form a solution, and when one of the bowls is empty, from one supply bowl to the other. A dual solid chemical supply system is described that incorporates the function of automatically switching the solution of the solid chemical dissolved in the bowl.

しかし、このようなシステムでは、固形薬剤を定量して溶媒に投入するなどして溶解度を調整しているため、注入濃度の調整が容易ではなかったり、装置が大掛かりになったりする。また、固形薬剤を飽和溶液まで溶解する場合は溶液濃度が一定であるために注入濃度の調整は比較的簡便になるが、飽和溶液であるために固形薬剤の析出等による注入不良のリスクが伴う。   However, in such a system, since the solubility is adjusted by quantifying the solid drug and putting it into the solvent, the adjustment of the injection concentration is not easy or the apparatus becomes large. In addition, when dissolving a solid drug up to a saturated solution, adjustment of the injection concentration is relatively simple because the solution concentration is constant, but because of the saturated solution, there is a risk of poor injection due to precipitation of the solid drug, etc. .

特許文献1に記載のような従来の固形薬剤供給システムにおいて、薬剤充填容器の固形薬剤の残量把握は、「のぞき窓」等による目視が一般的であるが、耐圧性等の容器の設計上、目視確認が困難な場合があり、その場合は固形薬剤の残量把握に問題がある。   In the conventional solid drug supply system as described in Patent Document 1, the remaining amount of the solid drug in the drug-filled container is generally visually checked with a “view window” or the like. In some cases, visual confirmation is difficult, and in this case, there is a problem in grasping the remaining amount of the solid medicine.

また、特許文献1に記載のような従来の固形薬剤供給システムにおいて、薬剤充填容器を複数配列した場合、各薬剤充填容器内の固形薬剤の消費量にばらつきがあるため、各薬剤充填容器内の固形薬剤を無駄なく使い切ることが困難である。   Moreover, in the conventional solid medicine supply system as described in Patent Document 1, when a plurality of medicine filling containers are arranged, the amount of solid medicine consumed in each medicine filling container varies. It is difficult to use up the solid drug without waste.

さらに、特許文献1に記載のような従来の固形薬剤供給システムにおいて、被処理液系と固形薬剤注入システムが配管等で密閉して接続されている場合、溶解液の逆流等のリスクがある。   Furthermore, in the conventional solid medicine supply system as described in Patent Document 1, when the liquid system to be treated and the solid medicine injection system are hermetically connected by piping or the like, there is a risk of backflow of the solution.

特開平10−235368号公報JP-A-10-235368 特許第4130588号公報Japanese Patent No. 4130588

「水処理薬品ハンドブック」、藤田賢二著、技報堂出版、4.2(3)「固形薬品の溶解設備」"Water treatment chemical handbook", Kenji Fujita, Gihodo Publishing, 4.2 (3) "Solid chemical dissolution equipment"

本発明の目的は、簡便な構成で、固形分の析出等による被処理液系の配管の閉塞が抑制され、被処理液中の薬剤濃度を微調整することができる固形薬剤供給装置および固形薬剤供給方法を提供することにある。   An object of the present invention is to provide a solid drug supply device and a solid drug capable of finely adjusting a drug concentration in a liquid to be treated with a simple configuration, in which clogging of a pipe of the liquid to be treated due to precipitation of solids or the like is suppressed It is to provide a supply method.

本発明は、固形薬剤を内部に充填した少なくとも1つの薬剤充填容器と、前記薬剤充填容器内の固形薬剤を溶解するために、前記薬剤充填容器内に溶媒を供給する溶媒供給手段と、前記固形薬剤が溶解された溶解液が流入する溶解液貯槽と、前記溶解液を希釈するために、希釈用溶媒を前記溶解液貯槽へ供給する希釈用溶媒供給手段と、前記溶解液貯槽内の前記溶解液の希釈溶液を被処理液系に供給するための希釈溶液供給手段と、を備え、前記薬剤充填容器が複数直列に配置され、直列に配置された前記薬剤充填容器群において、運転中に通液方向を逆転させる通液方向逆転手段を備える固形薬剤供給装置である。 The present invention includes at least one medicine filling container filled with a solid medicine, a solvent supply means for supplying a solvent into the medicine filling container in order to dissolve the solid medicine in the medicine filling container, and the solid A solution storage tank into which a solution in which a medicine is dissolved flows, a dilution solvent supply means for supplying a solvent for dilution to the solution storage tank in order to dilute the solution, and the dissolution in the solution storage tank Dilution solution supply means for supplying a diluted solution of the solution to the liquid system to be treated , wherein a plurality of the drug filling containers are arranged in series, and the drug filling container group arranged in series is passed during operation. a solid agent feeder Ru provided with a liquid passage direction reversing means for reversing the fluid direction.

また、前記固形薬剤供給装置において、前記薬剤充填容器の容器が光を透過する材質で構成されていることが好ましい。   In the solid medicine supply device, the container of the medicine filling container is preferably made of a material that transmits light.

また、前記固形薬剤供給装置において、前記薬剤充填容器から流出する前記溶解液の濃度を測定する濃度測定手段を備えることが好ましい。   Moreover, it is preferable that the solid medicine supply device includes a concentration measuring unit that measures the concentration of the solution flowing out of the medicine filling container.

また、前記固形薬剤供給装置において、前記溶解液の温度を測定する温度測定手段と、前記測定した温度に基づいて前記希釈用溶媒供給手段による希釈倍率を制御する制御手段と、を備えることが好ましい。   The solid drug supply device preferably includes a temperature measurement unit that measures the temperature of the solution, and a control unit that controls the dilution rate of the dilution solvent supply unit based on the measured temperature. .

また、本発明は、固形薬剤を内部に充填した少なくとも1つの薬剤充填容器内の固形薬剤を溶解するために、前記薬剤充填容器内に溶媒を供給する溶媒供給工程と、前記固形薬剤が溶解された溶解液が流入する溶解液貯槽へ、前記溶解液を希釈するために希釈用溶媒を供給する希釈用溶媒供給工程と、前記溶解液貯槽内の前記溶解液の希釈溶液を被処理液系に供給する希釈溶液供給工程と、を含み、前記薬剤充填容器が複数直列に配置され、直列に配置された前記薬剤充填容器群において、運転中に通液方向を逆転させる通液方向逆転工程を含む固形薬剤供給方法である。 The present invention also provides a solvent supply step of supplying a solvent into the drug filling container, and the solid drug is dissolved in order to dissolve the solid drug in at least one drug filling container filled with the solid drug. A diluting solvent supply step for supplying a diluting solvent to dilute the dissolved solution into the dissolved solution storage tank into which the dissolved solution flows, and a diluted solution of the dissolved solution in the dissolved solution storage tank to be treated liquid system look containing a dilution solution supply step of supplying, the drug filling container are arranged in a plurality in series, in the drug filling container group arranged in series, the liquid passing direction reversal process of reversing passed through direction during operation it is including solid agent supply method.

また、前記固形薬剤供給方法において、前記薬剤充填容器の容器が光を透過する材質で構成されていることが好ましい。   In the solid medicine supply method, the container of the medicine filling container is preferably made of a material that transmits light.

また、前記固形薬剤供給方法において、前記薬剤充填容器から流出する前記溶解液の濃度を測定する濃度測定工程を含むことが好ましい。   The solid medicine supply method preferably includes a concentration measurement step of measuring the concentration of the solution flowing out of the medicine filling container.

また、前記固形薬剤供給方法において、前記溶解液の温度を測定し、前記測定した温度に基づいて前記溶解液貯槽内の前記溶解液の希釈倍率を制御することが好ましい。   In the solid drug supply method, it is preferable that the temperature of the solution is measured, and the dilution rate of the solution in the solution storage tank is controlled based on the measured temperature.

本発明では、簡便な構成で、固形分の析出等による被処理液系の配管の閉塞が抑制され、被処理液中の薬剤濃度を微調整することができる。   In the present invention, with a simple configuration, the clogging of the pipe of the liquid to be treated due to precipitation of solids or the like is suppressed, and the chemical concentration in the liquid to be treated can be finely adjusted.

本発明の実施形態に係る固形薬剤供給装置および固形薬剤供給方法の一例を示す概略構成図である。It is a schematic structure figure showing an example of a solid medicine supply device and a solid medicine supply method concerning an embodiment of the present invention. 本発明の実施形態に係る固形薬剤供給方法の一例を示す概略構成図である。It is a schematic structure figure showing an example of a solid medicine supply method concerning an embodiment of the present invention. 本発明の実施形態に係る固形薬剤供給方法の一例を示す概略構成図である。It is a schematic structure figure showing an example of a solid medicine supply method concerning an embodiment of the present invention.

本発明の実施の形態について以下説明する。本実施形態は本発明を実施する一例であって、本発明は本実施形態に限定されるものではない。   Embodiments of the present invention will be described below. This embodiment is an example for carrying out the present invention, and the present invention is not limited to this embodiment.

本発明の実施形態に係る固形薬剤供給装置の一例の概略構成を図1に示し、その構成について説明する。固形薬剤供給装置1は、溶媒貯槽10と、少なくとも1つの薬剤充填容器12と、大気開放された溶解液貯槽14とを備える。図1の例では、薬剤充填容器12は、4つの薬剤充填容器12a,12b,12c,12dを備える。   FIG. 1 shows a schematic configuration of an example of a solid drug supply device according to an embodiment of the present invention, and the configuration will be described. The solid drug supply device 1 includes a solvent storage tank 10, at least one drug filling container 12, and a solution storage tank 14 opened to the atmosphere. In the example of FIG. 1, the medicine filling container 12 includes four medicine filling containers 12a, 12b, 12c, and 12d.

固形薬剤供給装置1において、溶媒貯槽10の入口には、溶媒ライン16が接続され、溶媒貯槽10の出口と薬剤充填容器12aの入口とは、ポンプ32を介して溶媒供給ライン18により接続されている。薬剤充填容器12aの出口と薬剤充填容器12bの入口、薬剤充填容器12bの出口と薬剤充填容器12cの入口、薬剤充填容器12cの出口と薬剤充填容器12dの入口、薬剤充填容器12dの出口と溶解液貯槽14の入口は、それぞれ溶解液ライン20a,20b,20c,20dにより接続されている。溶媒貯槽10の出口と溶解液貯槽14の入口は、ポンプ34を介して希釈用溶媒ライン22により接続されている。溶解液貯槽14の出口には、ポンプ36を介して希釈溶液供給ライン24が接続されている。溶解液ライン20における濃度測定点26には、濃度測定手段としての濃度測定装置28が設置されている。溶解液貯槽14には、温度測定手段として、温度測定装置30が設置されている。図1の例では、溶媒貯槽10、ポンプ32および溶媒供給ライン18が溶媒供給手段として機能し、溶媒貯槽10、ポンプ34および希釈用溶媒ライン22が希釈用溶媒供給手段として機能し、溶解液貯槽14、ポンプ36および希釈溶液供給ライン24が希釈溶液供給手段として機能する。   In the solid drug supply device 1, the solvent line 16 is connected to the inlet of the solvent storage tank 10, and the outlet of the solvent storage tank 10 and the inlet of the drug filling container 12 a are connected by the solvent supply line 18 via the pump 32. Yes. The outlet of the medicine filling container 12a and the inlet of the medicine filling container 12b, the outlet of the medicine filling container 12b and the inlet of the medicine filling container 12c, the outlet of the medicine filling container 12c and the inlet of the medicine filling container 12d, and the outlet and outlet of the medicine filling container 12d. The inlets of the liquid storage tank 14 are connected by the solution lines 20a, 20b, 20c, and 20d, respectively. The outlet of the solvent storage tank 10 and the inlet of the solution storage tank 14 are connected by a dilution solvent line 22 via a pump 34. A diluted solution supply line 24 is connected to the outlet of the solution storage tank 14 via a pump 36. A concentration measuring device 28 as a concentration measuring means is installed at the concentration measuring point 26 in the dissolving liquid line 20. The solution storage tank 14 is provided with a temperature measuring device 30 as temperature measuring means. In the example of FIG. 1, the solvent storage tank 10, the pump 32, and the solvent supply line 18 function as solvent supply means, and the solvent storage tank 10, the pump 34, and the dilution solvent line 22 function as dilution solvent supply means, and a solution storage tank 14, the pump 36 and the diluted solution supply line 24 function as a diluted solution supply means.

本実施形態に係る固形薬剤供給方法および固形薬剤供給装置1の動作について説明する。まず、溶媒の供給元より、溶媒ライン16を通して溶媒を溶媒貯槽10に溜める。溶媒貯槽10からポンプ32により溶媒供給ライン18を通して、直列に配置された薬剤充填容器12a,12b,12c,12dに溶媒を順次供給、通液する(溶媒供給工程)。末端の薬剤充填容器12dから流出してきた溶解液は、溶解液貯槽14に溜められる。溶媒貯槽10からポンプ34により希釈用溶媒ライン22を通して、溶解液貯槽14に希釈用溶媒を所定量供給し、溶解液を所定の濃度まで希釈する(希釈用溶媒供給工程)。溶解液貯槽14からポンプ36により希釈溶液供給ライン24を通して、所定の濃度に希釈された希釈溶液を被処理液系に供給する(希釈溶液供給工程)。なお、溶媒貯槽10とは別に希釈用溶媒を貯留する希釈用溶媒貯槽を設け、希釈用溶媒貯槽から希釈用溶媒ラインを通して、溶解液貯槽14に希釈用溶媒を所定量供給してもよい。   The operation of the solid medicine supply method and the solid medicine supply apparatus 1 according to this embodiment will be described. First, the solvent is stored in the solvent storage tank 10 from the solvent supply source through the solvent line 16. The solvent is sequentially supplied from the solvent storage tank 10 through the solvent supply line 18 by the pump 32 to the drug filling containers 12a, 12b, 12c, and 12d arranged in series, and the liquid is passed (solvent supply process). The solution flowing out from the terminal drug filling container 12 d is stored in the solution storage tank 14. A predetermined amount of dilution solvent is supplied from the solvent storage tank 10 to the dissolution liquid storage tank 14 through the dilution solvent line 22 by the pump 34, and the dissolution liquid is diluted to a predetermined concentration (dilution solvent supply step). A diluted solution diluted to a predetermined concentration is supplied from the solution storage tank 14 to the liquid system to be processed through the diluted solution supply line 24 by the pump 36 (diluted solution supplying step). A dilution solvent storage tank that stores the dilution solvent may be provided separately from the solvent storage tank 10, and a predetermined amount of the dilution solvent may be supplied from the dilution solvent storage tank to the solution storage tank 14 through the dilution solvent line.

固形薬剤を容器に充填し、その薬剤充填容器に溶媒を通液することで、または、複数の薬剤充填容器を直列に配置し、配置された薬剤充填容器12の群に溶媒を通液することで、撹拌等の操作を行わなくても、薬剤充填容器12の群の末端の容器出口から薬剤が溶媒に十分溶解した溶解液が得られる。得られた溶解液を溶解液貯槽14に溜め、希釈用溶媒により所定の濃度に希釈し、所定の濃度に希釈された希釈溶液を、溶解液貯槽14からポンプ36を用い、被処理液系に添加する。これにより、被処理液系の注入系統内での溶解液の過飽和による析出リスクを低減し、被処理液系への注入不良を抑制することができる。   Filling a container with a solid drug and passing a solvent through the drug-filled container, or arranging a plurality of drug-filled containers in series and passing the solvent through a group of arranged drug-filled containers 12 Thus, a solution in which the drug is sufficiently dissolved in the solvent can be obtained from the container outlet at the end of the group of drug-filled containers 12 without performing an operation such as stirring. The obtained solution is stored in the solution storage tank 14, diluted to a predetermined concentration with a solvent for dilution, and the diluted solution diluted to the predetermined concentration is transferred from the solution storage tank 14 to the liquid system to be treated using the pump 36. Added. Thereby, the risk of precipitation due to supersaturation of the solution in the injection system of the liquid system to be processed can be reduced, and poor injection into the liquid system to be processed can be suppressed.

本実施形態に係る固形薬剤供給方法および固形薬剤供給装置によれば、撹拌機や給粉機等を用いなくてもよく、簡便な構成の装置で運用することができる。また、被処理液系の配管(主配管、バイパス配管等)とは別の独立した配管系に薬剤充填容器を組み込み、さらに希釈溶液を用いるため、固形分の析出等による被処理液系の配管の閉塞等が抑制されて運用することができる。また、飽和溶液ではなく希釈溶液を用いるため、被処理液中の薬剤濃度を微調整することができる。さらに、固形薬剤の補充等のメンテナンス等の際に、固形薬剤およびその溶解液等の作業者への接触を抑制することができる。   According to the solid medicine supply method and the solid medicine supply apparatus according to the present embodiment, it is not necessary to use a stirrer or a powder feeder, and the apparatus can be operated with an apparatus having a simple configuration. In addition, since the drug-filled container is installed in an independent piping system different from the piping of the liquid to be treated (main piping, bypass piping, etc.) and the diluted solution is used, the piping of the liquid to be treated due to precipitation of solids, etc. It is possible to operate with reduced blockage and the like. Further, since the diluted solution is used instead of the saturated solution, the chemical concentration in the liquid to be treated can be finely adjusted. Furthermore, it is possible to suppress contact of the solid drug and its solution with the operator during maintenance such as replenishment of the solid drug.

薬剤充填容器12に通液する溶媒としては、用いる固形薬剤を溶解することができるものであればよく、特に制限はない。溶媒は、例えば、水、有機溶媒等である。希釈用溶媒は、通常は薬剤充填容器12に通液する溶媒と同じものが用いられるが、異なっていてもよい。   The solvent that passes through the drug filling container 12 is not particularly limited as long as it can dissolve the solid drug to be used. Examples of the solvent include water and organic solvents. As the solvent for dilution, the same solvent that is usually passed through the drug filling container 12 is used, but it may be different.

溶媒は、例えば、現場で得られる工業用水や場合によっては被処理液(被処理水)系の被処理液(被処理水)等であり、溶媒の供給元(工業用水水道、被処理液系等)と本実施形態に係る固形薬剤供給装置とを接続する必要があるが、この場合、「被処理液系と薬剤充填容器群」の間に、大気開放された溶解液貯槽14という大気開放区間を設けることで、これらを“縁切り”し、「被処理液系→薬剤充填容器群」という逆流を抑制することができる。さらに、「溶媒供給元と薬剤充填容器群」の間に、大気開放された溶媒貯槽10という大気開放区間を設ければ、これらを“縁切り”し、「薬剤充填容器群→溶媒供給元」という逆流を抑制することができる。   The solvent is, for example, industrial water obtained in the field or, depending on circumstances, a liquid to be treated (treated water), a liquid to be treated (treated water), etc., and a solvent supply source (industrial water tap, liquid to be treated) Etc.) and the solid drug supply device according to the present embodiment must be connected. In this case, the solution storage tank 14 opened to the atmosphere between the “liquid system to be treated and the drug filling container group” is opened to the atmosphere. By providing the section, these can be “bordered” and the backflow of “the liquid system to be treated → the group of drug-filled containers” can be suppressed. Furthermore, if an air release section called the solvent storage tank 10 opened to the atmosphere is provided between the “solvent supply source and the drug filling container group”, these are “bordered” and called “drug filling container group → solvent supply source”. Backflow can be suppressed.

固形薬剤を充填する容器としては、密閉系の容器であればよく、特に制限はない。例えば、カートリッジ型容器、ボンベ型容器等が挙げられる。固形薬剤を充填する容器をカートリッジ型容器とすることで、メンテナンス等の際に作業者が薬剤自体に直接触れるリスクを大幅に低減することができる。カートリッジ型容器としては、例えば、円筒状等の筒状の容器と、容器を密閉する蓋部と、容器または蓋部に設けられた流入口と、ストレーナ等のろ過装置に接続された流出管と、流出管に接続され、容器または蓋部に設けられた流出口とを備えるカートリッジ等を用いることができる。   The container for filling the solid drug is not particularly limited as long as it is a sealed container. For example, a cartridge type container, a cylinder type container, etc. are mentioned. By making the container filled with the solid medicine into a cartridge-type container, it is possible to greatly reduce the risk that an operator directly touches the medicine itself during maintenance or the like. As the cartridge type container, for example, a cylindrical container such as a cylindrical shape, a lid for sealing the container, an inlet provided in the container or the lid, and an outflow pipe connected to a filtration device such as a strainer A cartridge or the like that is connected to the outflow pipe and includes an outlet provided in the container or the lid can be used.

薬剤充填容器の数は1つ以上であればよく、特に制限はないが、後述するように“薬剤枯渇”を見過ごすリスクを低減するために、2つ以上であることが好ましい。   The number of drug filling containers may be one or more, and is not particularly limited, but is preferably two or more in order to reduce the risk of overlooking “drug depletion” as described later.

また、固形薬剤を充填する容器が光を透過する材質で構成されていることが好ましい。これにより、薬剤充填容器12内の固形薬剤の残量を容易に把握することができる。例えば、薬剤充填容器12の外部から光を照射することにより、容器内部を透けさせ、目視により薬剤充填容器12内の薬剤の残量を把握すればよい。光を透過する材質としては、例えば、PE(ポリエチレン)、FRP(繊維強化プラスチック)等の樹脂等が挙げられる。   Moreover, it is preferable that the container filled with the solid medicine is made of a material that transmits light. Thereby, the residual amount of the solid medicine in the medicine filling container 12 can be easily grasped. For example, by irradiating light from the outside of the medicine filling container 12, the inside of the container can be seen through and the remaining amount of medicine in the medicine filling container 12 can be grasped visually. Examples of the material that transmits light include resins such as PE (polyethylene) and FRP (fiber reinforced plastic).

「固形薬剤」とは、粉体、粒状、タブレット型等を含め、形状に特に制限はなく、固体である薬剤全てを指し、例えば、殺菌剤、分散剤、防食剤等が挙げられる。固形薬剤としては、例えば、DBNPA(2,2−ジブロモ−3−ニトリロプロピオンアミド)等の殺菌剤やヘキサメタリン酸等の分散剤等が挙げられる。カートリッジ型容器にDBNPA等を充填したものを商品形態として運用すれば、作業者に殺菌剤等の薬剤が直接触れるリスクを大幅に低減することができる。   “Solid medicine” includes powder, granule, tablet type and the like, and there are no particular restrictions on the shape, and refers to all medicines that are solid, for example, bactericides, dispersants, anticorrosives and the like. Examples of the solid drug include bactericides such as DBNPA (2,2-dibromo-3-nitrilopropionamide) and dispersants such as hexametaphosphoric acid. If a cartridge-type container filled with DBNPA or the like is used as a product form, the risk of direct contact of chemicals such as bactericides with the worker can be greatly reduced.

容器への薬剤の充填量としては、特に制限はないが、例えば、人力で運搬することができる総重量30kg以内程度であればよい。   Although there is no restriction | limiting in particular as the filling amount of the chemical | medical agent to a container, For example, what is necessary is just about less than the total weight of 30 kg which can be conveyed manually.

溶解液貯槽14における溶解液の希釈倍率としては、用いる固形薬剤の種類等に応じて適宜設定すればよく、特に制限はないが、析出リスク等を考慮すると、例えば、固形薬剤の溶媒に対する飽和濃度の1/10〜1/2程度とすればよい。   The dilution ratio of the dissolution liquid in the dissolution liquid storage tank 14 may be appropriately set according to the type of the solid drug to be used and is not particularly limited. However, considering the precipitation risk, for example, the saturated concentration of the solid drug with respect to the solvent About 1/10 to 1/2.

溶解液貯槽14には、希釈溶液中の溶け残りの薬剤等を除去するために、ストレーナ等のろ過手段を設置してもよい。   The dissolution liquid storage tank 14 may be provided with a filtering means such as a strainer in order to remove undissolved chemicals in the diluted solution.

本実施形態において、温度測定装置30により溶解液貯槽14における溶解液の温度を測定し、この測定した温度に基づいて、図示しない制御手段により溶解液貯槽14内の溶解液の希釈倍率を制御することが好ましい。溶解液の希釈倍率の制御は、例えば、溶媒貯槽10等からの希釈用溶媒ライン22に設けたポンプ34を制御し、希釈用溶媒の流量を調整して行えばよい。   In the present embodiment, the temperature of the dissolution liquid in the dissolution liquid storage tank 14 is measured by the temperature measuring device 30, and the dilution rate of the dissolution liquid in the dissolution liquid storage tank 14 is controlled by a control means (not shown) based on the measured temperature. It is preferable. The dilution rate of the solution may be controlled, for example, by controlling the pump 34 provided in the dilution solvent line 22 from the solvent storage tank 10 or the like and adjusting the flow rate of the dilution solvent.

薬剤充填容器12から流出する溶解液は「飽和状態」であると考えると、予め溶質である固形薬剤の溶媒に対する飽和溶解度曲線を把握しておけば、溶解液の温度から溶解液中の薬剤の濃度を予想することができる。つまり溶解液の温度によって溶解液濃度が把握できるため、溶解液の温度に基づいて溶解液の希釈倍率を制御すれば、濃度の変動の少ない「希釈溶液」を得ることができる。希釈溶液の濃度の変動が少なければ、被処理液系への希釈溶液の添加濃度の調整も容易となる。   Assuming that the solution flowing out from the drug filling container 12 is “saturated”, if the saturation solubility curve for the solvent of the solid drug as the solute is grasped in advance, the temperature of the drug in the solution is determined from the temperature of the solution. The concentration can be predicted. That is, since the concentration of the dissolved solution can be grasped based on the temperature of the dissolved solution, if the dilution rate of the dissolved solution is controlled based on the temperature of the dissolved solution, it is possible to obtain a “diluted solution” with little variation in concentration. If there is little variation in the concentration of the diluted solution, it is easy to adjust the concentration of the diluted solution added to the liquid system to be treated.

本実施形態において、薬剤充填容器12から流出する溶解液の濃度を測定する(濃度測定工程)ことが好ましい。濃度測定装置28により薬剤充填容器12から流出する溶解液の濃度を測定することにより、その薬剤充填容器の上流側の容器内の薬剤の有無を確認することができ、薬剤の残量を把握することができる。   In the present embodiment, it is preferable to measure the concentration of the solution flowing out from the drug filling container 12 (concentration measuring step). By measuring the concentration of the solution flowing out of the drug filling container 12 with the concentration measuring device 28, it is possible to confirm the presence or absence of the drug in the container on the upstream side of the drug filling container, and grasp the remaining amount of the drug. be able to.

濃度測定装置28としては、溶解液の濃度を測定することができるものであればよく、特に制限はないが、例えば、溶解液の導電率を測定する導電率測定装置、TOC(全有機炭素)測定装置、pH測定装置、ORP(酸化還元電位)測定装置等が挙げられる。これらのうち、運用上の測定精度等の点から、導電率を測定することが好ましい。   The concentration measuring device 28 is not particularly limited as long as it can measure the concentration of the dissolved solution. For example, a conductivity measuring device that measures the conductivity of the dissolved solution, TOC (total organic carbon). A measuring device, a pH measuring device, an ORP (oxidation reduction potential) measuring device, etc. are mentioned. Among these, it is preferable to measure conductivity from the viewpoint of operational measurement accuracy and the like.

濃度測定装置28による濃度測定点26の位置は、溶解液ライン20における少なくとも1点であればよい。   The position of the concentration measuring point 26 by the concentration measuring device 28 may be at least one point in the solution line 20.

また、本実施形態において、薬剤充填容器12が複数直列に配置され、直列に配置された薬剤充填容器12の群において、運転中に通液方向を逆転させる(通液方向逆転工程)ことが好ましい。   Moreover, in this embodiment, it is preferable that a plurality of drug filling containers 12 are arranged in series, and in the group of drug filling containers 12 arranged in series, the liquid passing direction is reversed during operation (liquid flowing direction reversing step). .

薬剤充填容器12の群の途中の溶解液ライン20における少なくとも1点に設置された濃度測定点26において、濃度測定装置28により薬剤の残量を把握し、ある濃度測定点26において、薬剤の「残量なし」と判断された場合は、その濃度測定点26の上流側の薬剤充填容器12内の薬剤はほぼ消費されたと判断し、新品の薬剤充填容器と交換すればよい。また、新品の薬剤充填容器と交換した後、溶媒の通液方向を逆転し、運転を再開してもよい。これにより、充填した薬剤を無駄なく使用することができ、かつ薬剤の消費を認知しやすい。   At a concentration measurement point 26 installed at least at one point in the solution line 20 in the middle of the group of the drug filling containers 12, the remaining amount of the drug is grasped by the concentration measurement device 28, and at a certain concentration measurement point 26, the drug “ When it is determined that there is no remaining amount, it is determined that the medicine in the medicine filling container 12 on the upstream side of the concentration measurement point 26 is almost consumed, and it may be replaced with a new medicine filling container. Moreover, after replacing | exchanging with a new chemical | medical agent filling container, the liquid flow direction of a solvent may be reversed and operation | movement may be restarted. Thereby, the filled medicine can be used without waste, and the consumption of the medicine can be easily recognized.

例えば、図2に示すように、直列に配列された薬剤充填容器12の群(図2の例では、薬剤充填容器12a,12b,12c,12d)に溶媒を通液する場合、基本的に上流側の薬剤充填容器内の薬剤から溶解し、消費されていく。このため、薬剤充填容器12の群の途中の溶解液ライン20における濃度測定点26(図2の例では、薬剤充填容器12bと薬剤充填容器12cとの間の溶解液ライン20bに設置されている)において、薬剤の残量有無を調べて「残量なし」ということが分かれば、濃度測定点26より上流側の薬剤充填容器12内(図2の例では、薬剤充填容器12a,12b)は全て「残量なし」と判断することができる。また、濃度測定点26より下流側の薬剤充填容器12(図2の例では、薬剤充填容器12c,12d)が「残量なし」となるにはさらに時間的猶予があるため、固形薬剤供給装置全体として、“薬剤枯渇”を見過ごすリスクが低減される。例えば、図3に示すように、「残量なし」と判断された薬剤充填容器12(図2、図3の例では、薬剤充填容器12a,12b)を全て新しいものに交換し、交換後、溶媒の通液方向を逆転(図3の例では、薬剤充填容器12d→12c→12b→12a)させれば、新しい薬剤充填容器(図3の例では、薬剤充填容器12a,12b)が濃度測定点26よりも下流側に配置されることになるため、薬剤の残量が「濃度測定点26より上流側<濃度測定点26より下流側」という状態が保たれ、“薬剤枯渇”を見過ごすリスクが低い状態が保たれる。しかし、新しい薬剤充填容器に交換後に通液方向を逆転させなければ、薬剤の残量が「濃度測定点26より上流側>濃度測定点26より下流側」となり、濃度測定点26において薬剤の「残量なし」となった時点で、すでに固形薬剤供給装置全体としても薬剤が枯渇してしまう場合が考えられ、固形薬剤供給装置全体として、“薬剤枯渇”を見過ごすリスクが増加する。   For example, as shown in FIG. 2, when a solvent is passed through a group of drug filling containers 12 arranged in series (in the example of FIG. 2, drug filling containers 12a, 12b, 12c, 12d), basically, upstream Dissolved from the drug in the drug container on the side and consumed. For this reason, the concentration measurement point 26 in the dissolution liquid line 20 in the middle of the group of the drug filling containers 12 (in the example of FIG. 2, it is installed in the dissolution liquid line 20b between the drug filling container 12b and the drug filling container 12c. In FIG. 2, if it is determined that there is no remaining amount of the medicine and it is found that there is no remaining amount, the inside of the medicine filling container 12 upstream of the concentration measuring point 26 (the medicine filling containers 12a and 12b in the example of FIG. 2) All can be determined as “no remaining amount”. In addition, since the drug filling container 12 (in the example of FIG. 2, the drug filling containers 12c and 12d in the example of FIG. 2) on the downstream side of the concentration measuring point 26 has a further time delay, The risk of overlooking “drug depletion” is reduced. For example, as shown in FIG. 3, the medicine filling container 12 determined to be “no remaining amount” (in the example of FIGS. 2 and 3, the medicine filling containers 12 a and 12 b) are all replaced with new ones. If the solvent flow direction is reversed (in the example of FIG. 3, the drug filling containers 12d → 12c → 12b → 12a), the concentration of the new drug filling containers (the drug filling containers 12a and 12b in the example of FIG. 3) is measured. Since it is arranged downstream of the point 26, the state that the remaining amount of the drug is “upstream from the concentration measurement point 26 <downstream from the concentration measurement point 26” is maintained, and the risk of overlooking “drug depletion” Is kept low. However, if the liquid flow direction is not reversed after replacement with a new drug-filled container, the remaining amount of the drug becomes “upstream from the concentration measurement point 26> downstream from the concentration measurement point 26”. When the “no remaining amount” is reached, the solid drug supply device as a whole may already be depleted, increasing the risk of overlooking the “drug depletion” as a whole solid drug supply device.

濃度測定点26は、薬剤充填容器12の群の途中の溶解液ライン20のいずれかの場所に設置すればよく、特に制限はないが、運用上の利便性等の点から、薬剤充填容器12の群の中間の溶解液ライン20(図1〜図3の例では、4つの薬剤充填容器12a,12b,12c,12dの中間の溶解液ライン20b)に設置することが好ましい。   The concentration measurement point 26 may be installed anywhere in the solution line 20 in the middle of the group of drug-filled containers 12, and is not particularly limited, but from the viewpoint of operational convenience, the drug-filled container 12. It is preferable to install in the middle dissolution liquid line 20 (in the example of FIGS. 1 to 3, the middle dissolution liquid line 20b of the four drug filling containers 12a, 12b, 12c, and 12d).

通液方向逆転手段としては、ラインの切替バルブ等が挙げられる。   Examples of the liquid flow direction reversing means include a line switching valve.

図1〜図3の例では、4つの薬剤充填容器12a,12b,12c,12dが直列に接続されているが、複数の薬剤充填容器を円周上等に配置し、流路を切り替え、あたかもメリーゴーランドのように各薬剤充填容器の通水順序を順繰りに切り替え制御するメリーゴーランド方式であってもよい。   In the example of FIGS. 1 to 3, four drug filling containers 12a, 12b, 12c, and 12d are connected in series. However, a plurality of drug filling containers are arranged on the circumference and the flow paths are switched, as if It may be a merry-go-round system that switches and sequentially controls the water flow order of each drug-filled container as in a merry-go-round.

本実施形態に係る固形薬剤供給方法および固形薬剤供給装置を適用可能な被処理液系としては、固形薬剤を用いる系であればよく、特に制限はないが、例えば、冷却水処理系、排水処理系、工業用水処理系、純水処理系等の各種水処理系全般に適用することができる。また、例えば、系内の圧力条件が比較的高いRO膜(例えば、0.75MPa程度)等の膜処理を含む各種水処理系の場合、系内に固形薬剤供給装置を組み込むのは困難であるため、大気開放区間を設けた本実施形態に係る固形薬剤供給方法および固形薬剤供給装置を好適に適用することができる。   The treatment liquid system to which the solid medicine supply method and the solid medicine supply apparatus according to the present embodiment can be applied is not particularly limited as long as it is a system using a solid medicine, and includes, for example, a cooling water treatment system and waste water treatment. It can be applied to all types of water treatment systems such as water treatment systems, industrial water treatment systems, and pure water treatment systems. Further, for example, in the case of various water treatment systems including a membrane treatment such as an RO membrane (for example, about 0.75 MPa) having a relatively high pressure condition in the system, it is difficult to incorporate a solid drug supply device in the system. Therefore, the solid medicine supply method and the solid medicine supply apparatus according to the present embodiment provided with an air release section can be suitably applied.

以下、実施例および比較例を挙げ、本発明をより具体的に詳細に説明するが、本発明は、以下の実施例に限定されるものではない。   Hereinafter, although an example and a comparative example are given and the present invention is explained more concretely in detail, the present invention is not limited to the following examples.

<実施例1>
図1の固形薬剤供給装置を用い、固形のDBNPAの希釈溶液を調製し、被処理液系としてRO膜系に適用した。具体的には、以下の方法で行った。
(1)固形のDBNPAを10kg充填した円筒型の薬剤充填容器(材質:FRP)を4本直列に配列し、その薬剤充填容器内に溶媒として水を通水する。
(2)末端の薬剤充填容器の出口から流出したDBNPA溶解液をDBNPA溶解液貯槽に貯留する。
(3)希釈用溶媒としての水をDBNPA溶解液貯槽に供給し、2倍希釈する。
(4)2倍希釈されたDBNPA溶解液を、RO膜へ被処理液を供給する配管に薬注ポンプで薬注する。
その結果、簡便な構成で、固形分の析出による被処理液系の配管の閉塞が抑制され、被処理液中の薬剤濃度を微調整することができた。
<Example 1>
A solid DBNPA dilution solution was prepared using the solid drug supply apparatus of FIG. 1 and applied to the RO membrane system as a liquid system to be treated. Specifically, the following method was used.
(1) Four cylindrical drug filling containers (material: FRP) filled with 10 kg of solid DBNPA are arranged in series, and water is passed through the drug filling container as a solvent.
(2) The DBNPA solution flowing out from the outlet of the terminal drug filling container is stored in a DBNPA solution storage tank.
(3) Water as a solvent for dilution is supplied to the DBNPA solution storage tank and diluted twice.
(4) A 2-fold diluted DBNPA solution is poured into a pipe for supplying the liquid to be processed to the RO membrane with a chemical pump.
As a result, it was possible to finely adjust the chemical concentration in the liquid to be treated with a simple configuration, which suppresses the clogging of the pipes in the liquid to be treated due to the precipitation of solids.

<比較例1>
RO膜へ被処理液を供給する配管にバイパス配管を設け、そこに直接、薬剤充填容器を組み込み、希釈溶液を調製した。具体的には、実施例1同様、固形のDBNPA10kgを充填した円筒型の薬剤充填容器を組み込んだ。その結果、固形分の析出による被処理液系の配管の閉塞、具体的にはストレーナ部分の閉塞が発生した。また、被処理液中の薬剤濃度を微調整することができなかった。
<Comparative Example 1>
A bypass pipe was provided in a pipe for supplying the liquid to be processed to the RO membrane, and a drug-filled container was directly incorporated therein to prepare a diluted solution. Specifically, as in Example 1, a cylindrical drug filling container filled with 10 kg of solid DBNPA was incorporated. As a result, clogging of the pipe of the liquid system to be treated due to solid content precipitation, specifically, clogging of the strainer portion occurred. Moreover, the chemical concentration in the liquid to be treated could not be finely adjusted.

1 固形薬剤供給装置、10 溶媒貯槽、12,12a,12b,12c,12d 薬剤充填容器、14 溶解液貯槽、16 溶媒ライン、18 溶媒供給ライン、20,20a,20b,20c,20d 溶解液ライン、22 希釈用溶媒ライン、24 希釈溶液供給ライン、26 濃度測定点、28 濃度測定装置、30 温度測定装置、32,34,36 ポンプ。   DESCRIPTION OF SYMBOLS 1 Solid chemical | medical agent supply apparatus, 10 Solvent storage tank, 12, 12a, 12b, 12c, 12d Chemical filling container, 14 Dissolution liquid storage tank, 16 Solvent line, 18 Solvent supply line, 20, 20a, 20b, 20c, 20d Dissolution liquid line, 22 Dilution solvent line, 24 Dilution solution supply line, 26 Concentration measurement point, 28 Concentration measurement device, 30 Temperature measurement device, 32, 34, 36 Pump.

Claims (8)

固形薬剤を内部に充填した少なくとも1つの薬剤充填容器と、
前記薬剤充填容器内の固形薬剤を溶解するために、前記薬剤充填容器内に溶媒を供給する溶媒供給手段と、
前記固形薬剤が溶解された溶解液が流入する溶解液貯槽と、
前記溶解液を希釈するために、希釈用溶媒を前記溶解液貯槽へ供給する希釈用溶媒供給手段と、
前記溶解液貯槽内の前記溶解液の希釈溶液を被処理液系に供給するための希釈溶液供給手段と、
を備え
前記薬剤充填容器が複数直列に配置され、直列に配置された前記薬剤充填容器群において、運転中に通液方向を逆転させる通液方向逆転手段を備えることを特徴とする固形薬剤供給装置。
At least one drug filling container filled with a solid drug;
A solvent supply means for supplying a solvent into the drug filling container to dissolve the solid drug in the drug filling container;
A solution storage tank into which a solution in which the solid medicine is dissolved flows;
In order to dilute the solution, a dilution solvent supply means for supplying a dilution solvent to the solution storage tank,
A diluted solution supply means for supplying a diluted solution of the dissolved solution in the dissolved solution storage tank to a liquid system to be treated;
Equipped with a,
The drug filling container are arranged in a plurality in series, in the drug filling container group arranged in series, solid agent supply device according to claim Rukoto comprises a liquid passage direction reversing means for reversing the passed through direction during operation.
請求項1に記載の固形薬剤供給装置であって、
前記薬剤充填容器の容器が光を透過する材質で構成されていることを特徴とする固形薬剤供給装置。
The solid drug supply device according to claim 1,
A solid medicine supply device, wherein the medicine filling container is made of a material that transmits light.
請求項1または2に記載の固形薬剤供給装置であって、
前記薬剤充填容器から流出する前記溶解液の濃度を測定する濃度測定手段を備えることを特徴とする固形薬剤供給装置。
The solid medicine supply device according to claim 1 or 2 ,
A solid drug supply device comprising a concentration measuring means for measuring the concentration of the solution flowing out of the drug filling container.
請求項1〜のいずれか1項に記載の固形薬剤供給装置であって、
前記溶解液の温度を測定する温度測定手段と、
前記測定した温度に基づいて前記希釈用溶媒供給手段による希釈倍率を制御する制御手段と、
を備えることを特徴とする固形薬剤供給装置。
It is a solid medicine supply device given in any 1 paragraph of Claims 1-3 ,
Temperature measuring means for measuring the temperature of the solution;
Control means for controlling the dilution factor by the dilution solvent supply means based on the measured temperature;
A solid drug supply device comprising:
固形薬剤を内部に充填した少なくとも1つの薬剤充填容器内の固形薬剤を溶解するために、前記薬剤充填容器内に溶媒を供給する溶媒供給工程と、
前記固形薬剤が溶解された溶解液が流入する溶解液貯槽へ、前記溶解液を希釈するために希釈用溶媒を供給する希釈用溶媒供給工程と、
前記溶解液貯槽内の前記溶解液の希釈溶液を被処理液系に供給する希釈溶液供給工程と、
を含み、
前記薬剤充填容器が複数直列に配置され、直列に配置された前記薬剤充填容器群において、運転中に通液方向を逆転させる通液方向逆転工程を含むことを特徴とする固形薬剤供給方法。
A solvent supply step of supplying a solvent into the drug-filled container in order to dissolve the solid drug in at least one drug-filled container filled with the solid drug;
A dilution solvent supply step of supplying a dilution solvent to dilute the solution into a solution storage tank into which the solution in which the solid drug is dissolved flows;
A diluted solution supplying step of supplying a diluted solution of the dissolved solution in the dissolved solution storage tank to the liquid system to be treated;
Only including,
The drug filling container are arranged in a plurality in series, in the drug filling container group arranged in series, solid agent supply method comprising including Mukoto the liquid passage direction reversal process of reversing passed through direction during operation.
請求項に記載の固形薬剤供給方法であって、
前記薬剤充填容器の容器が光を透過する材質で構成されていることを特徴とする固形薬剤供給方法。
The solid drug supply method according to claim 5 ,
A solid drug supply method, wherein the container of the drug filling container is made of a material that transmits light.
請求項5または6に記載の固形薬剤供給方法であって、
前記薬剤充填容器から流出する前記溶解液の濃度を測定する濃度測定工程を含むことを特徴とする固形薬剤供給方法。
It is a solid medicine supply method according to claim 5 or 6 ,
A solid drug supply method comprising a concentration measurement step of measuring the concentration of the solution flowing out of the drug filling container.
請求項のいずれか1項に記載の固形薬剤供給方法であって、
前記溶解液の温度を測定し、前記測定した温度に基づいて前記溶解液貯槽内の前記溶解液の希釈倍率を制御することを特徴とする固形薬剤供給方法。
A solid drug supply method according to any one of claims 5-7,
A method of supplying a solid drug, wherein the temperature of the solution is measured, and the dilution rate of the solution in the solution storage tank is controlled based on the measured temperature.
JP2011230453A 2011-10-20 2011-10-20 Solid drug supply apparatus and solid drug supply method Expired - Fee Related JP5826586B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011230453A JP5826586B2 (en) 2011-10-20 2011-10-20 Solid drug supply apparatus and solid drug supply method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011230453A JP5826586B2 (en) 2011-10-20 2011-10-20 Solid drug supply apparatus and solid drug supply method

Publications (2)

Publication Number Publication Date
JP2013086045A JP2013086045A (en) 2013-05-13
JP5826586B2 true JP5826586B2 (en) 2015-12-02

Family

ID=48530541

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011230453A Expired - Fee Related JP5826586B2 (en) 2011-10-20 2011-10-20 Solid drug supply apparatus and solid drug supply method

Country Status (1)

Country Link
JP (1) JP5826586B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102014207126A1 (en) 2013-04-16 2014-10-16 Honda Motor Co., Ltd. Exhaust gas recirculation control / control device for an internal combustion engine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0529057Y2 (en) * 1988-11-18 1993-07-26
JP3209843B2 (en) * 1993-10-15 2001-09-17 有限会社テエイク・ワン総合事務所 How to adjust and store ozone solution of predetermined concentration
JP3141919B2 (en) * 1994-10-13 2001-03-07 三菱瓦斯化学株式会社 Chemical liquid preparation apparatus and method
JPH11207161A (en) * 1998-01-22 1999-08-03 Konica Corp Device for dissolving solid treating agent
JP5149469B2 (en) * 2000-02-02 2013-02-20 栗田工業株式会社 Method for dissolving yield improver for paper process made of water-soluble polymer

Also Published As

Publication number Publication date
JP2013086045A (en) 2013-05-13

Similar Documents

Publication Publication Date Title
US8114298B2 (en) Method, device and system for water treatment
JP5924447B1 (en) Ship
JP2017100129A5 (en)
US6855252B2 (en) Chemical dispenser cartridge for filter devices
US10696575B1 (en) Water purification system
US6267886B1 (en) Uni-directional flow chemical dispenser
JP5826586B2 (en) Solid drug supply apparatus and solid drug supply method
JP2004526565A (en) Solid material melting equipment
CA2914813C (en) Monitored release solid feed system
JP5795235B2 (en) Separation membrane slime prevention method and separation membrane slime prevention device
US10894725B1 (en) Control process for wastewater treatment system
JP2012254402A (en) System for treating ship ballast water
BR112017007278B1 (en) CAPTURE UNIT FOR USE WITH AN ANTIMICROBIAL APPLICATION UNIT
EP3010621B1 (en) Monitored release solid feed system
JP7117285B2 (en) BALLAST WATER TREATMENT DEVICE AND BALLAST WATER TREATMENT METHOD
JP4894316B2 (en) Membrane damage detection method for membrane filtration process
JP6756298B2 (en) Ballast water treatment equipment and ballast water treatment method
KR101744461B1 (en) Processing and managing apparatus for chilling water
KR102385817B1 (en) A natural falling-type sodium hypochlorite injection device
JP2018047886A (en) Ship and ballast water treatment method
EP3290394B1 (en) Ballast water treatment device and ballast water treatment method
WO2017033848A1 (en) Ballast water treatment device and ballast water treatment method
KR102418570B1 (en) A sodium hypochlorite injection device
CN220012299U (en) Ultrafiltration water tank device and reverse osmosis flushing pipeline system
JP2009189969A (en) Fluid concentration adjustment method and adjustment apparatus and treatment system of organic wastewater using apparatus

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140603

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150210

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150326

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150929

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20151014

R150 Certificate of patent or registration of utility model

Ref document number: 5826586

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees